Normal infant by a gestational carrier for a phenylketonuria mother: Alternative therapy

Molecular Genetics and Metabolism

Volumn 82, Issue 1, 2004, Pages 83-86

  Fisch, Robert O ^a   Stassart, Jacques P ^b,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Repro Med Infertility Associates   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Alternative therapy; Gestational carrier; Maternal phenylketonuria; No diet; Normal child

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CHILD GROWTH; EMBRYO TRANSFER; FEMALE; FEMALE FERTILITY; FERTILIZATION; GESTATION PERIOD; GROWTH CURVE; HEAD CIRCUMFERENCE; HUMAN; LABOR INDUCTION; MATERNAL CARE; OOCYTE; PHENYLKETONURIA; PREGNANCY; PRIORITY JOURNAL; SPERM; UTERUS CAVITY;

COMPLEMENTARY THERAPIES; FEMALE; HUMANS; INFANT; MALE; PHENYLKETONURIA, MATERNAL; PREGNANCY; PREGNANCY OUTCOME; SURROGATE MOTHERS;

EID: 1942489238     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymgme.2004.02.005     Document Type: Article

References (32)

1. Naughten E., Saul I.P. Maternal phenylketonuria - the Irish experience. J. Inherit. Metab. Dis. 13:1990;658-664.
2. Koch R., Friedman E.G., Wenz E., Jew K., Crowley C., Donned G. Maternal phenylketonuria. J. Inherit. Metab. Dis. 9:1986;159-168.
3. Holtzman N.A., Kronmal R.A., von Doorninck W., Azen C., Koch R. Effect of age at loss of dietary control on intellectual performance and behavior of children with phenylketonuria. N. Engl. J. Med. 314:1986;593-598.
4. Rohr F.J., Doherty L.B., Waisbren S.E., Bailey I.V., Ampola M.G., Benacerraf B., Levy H.L. New England Maternal PKU Project: prospective study of untreated and treated pregnancies and their outcome. J. Pediatr. 110:1987;391-398.
5. Martin S.B., Acosta P.B. Nutrition support of phenylketonuria and maple syrup disease. Top. Clin. Nutr. 2:1987;9-24.
6. Farquhar D.L., Steven F., Westwood A. Preliminary report on inverse diurnal variation of phenylalanine: implication in maternal phenylketonuria. Hum. Nutr. Appl. Nutr. 39:1985;224-226.
7. Magee A.C., Ryan K., Moore A., Trimble E.R. Follow up of fetal outcome in cases of maternal phenylketonuria in Northern Ireland. Arch. Dis. Fetal Neonatal. 87:2002;141-143.
8. Fisch R.O., Tagatz G., Stassart J.P. Gestational carrier - a reproductive haven for offspring of mothers with phenylketonuria (PKU): an alternative therapy for maternal PKU. J. Inherit. Metab. Dis. 16:1993;957-961.
9. Utian W.H., Sheean L., Goldfarb J.M., Kiwi R. Successful pregnancy after in vitro fertilization and embryo transfer from an infertile woman to a surrogate. N. Engl. J. Med. 313:1985;1351-1352.
10. Utian W.H., Goldfarb J.M., Kiwi R., Sheean L.A. Preliminary experience with in vitro fertilization-surrogate gestational pregnancy. Fertil. Steril. 52:1989;633-638.
11. Sauer M.V., Paulson R.J. Understanding the current status of oocyte donation in the United States: what's really going out there? Fertil. Steril. 58:1992;16-18.
12. Mabry C.C., Denniston J.C., Nelson T.L. Maternal phenylketonuria. N. Engl. J. Med. 269:1963;1404-1408.
13. Fisch R.O., Walker W.A., Anderson J.A. Prenatal and postnatal developmental consequences of maternal phenylketonuria. Pediatrics. 37:1966;979-986.
14. Fisch R.O., Doeden D., Lansky L.L., Anderson J.A. Maternal phenylketonuria: detrimental effects on embryogenesis and fetal development. Am. J. Dis. Child. 118:1969;847-858.
15. Stevenson R.E., Huntley C.C. Congenital malformations in offspring of phenylketonuric mothers. Pediatrics. 40:1967;33-45.
16. Lenke R.R., Levy H.L. Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies. N. Engl. J. Med. 303:1980;1202-1208.
17. Fisch R.O., Burke B., Bass J., Ferrara T.B., Mastri A. Maternal phenylketonuria - chronology of detrimental effects on embryogenesis and fetal development: pathological report, survey, clinical application. Pediatr. Pathol. 5:1986;449-461.
18. Lipson A., Buehler B., Bartly J., Walsh D., Yu J., O'Halloran M., Webster W. Maternal phenylalaninemia fetal effects. J. Pediatr. 104:1984;216-220.
19. Davidson D.C., Isherwood D.M., Ireland J.T., Rae P.G. Outcome of pregnancy in a phenylketonuric mother after low phenylalanine diet introduced from nine week of pregnancy. Eur. J. Pediatr. 137:1981;45-48.
20. Tenbrinck M.S., Stroud H.W. Normal infant born to a mother with phenylketonuria. J. Am. Med. Assoc. 247:1982;2139-2140.
21. Bessman S.P. The justification theory: the essential nature of non-essential amino acid. Nutr. Rev. 37:1979;209-220.
22. Güttler F., Lou H., Andersen J., Kok K., Mikkelson I., Nielsen K.B., Nielsen J.B. Cognitive development in offspring of untreated and preconceptionally treated maternal phenylketonuria. J. Inherit. Metab. Dis. 13(4):1990;665-671.
23. Platt L.D., Koch R., Azen C., Hanley W.B., Levy H.L., Matalon R., Rouse B., de la Cruze F., Wala C.A. Maternal phenylketonuria collaborative study, obstetric aspects and outcome. Am. J. Obstet. Gynecol. 166:1992;1150-1160. discussion 1160-1162.
24. Jervis G.A. Genetics of phenylpyruvic oligophrenia. (Contribution to study of influence of heredity on mental defect). J. Ment. Sci. 85:1939;719-762.
25. Fisch R.O., Matalon R., Weisberg S., Michaels K. Children of fathers with phenylketonuria: an international survey. J. Pediatr. 118:1991;739-741.
26. Koch R., Friedman E., Azen C., Hanley W., Levy H., Matalon R., Rouse B., Trefz F., Waisbren S., Michals-Matalon K., Acosta P., Gütler F., Ullrich K., Platt L., dela Cruz F. The international collaborative study of maternal phenylketonuria: status report 1998. Eur. J. Pediatr. 159(Suppl. 2):2000;156-160.
27. Savage Brown A., Fernhoff P.M., Waisbren S.E., Frazier D.M., Singh R., Rohr F., Morris J.M., Kenneson A., MacDonald P., Gwinn M., Honein M., Rasmussen S.A. Barriers to successful dietary control among pregnant women with phenylketonuria. Genet. Med. 4(2):2002;84-89.
28. Rouse B., Matalon R., Koch R., Azen C., Levy H., Hanley W., Trefz F., de la Cruz F. Maternal phenylketonuria syndrome: congenital heart defects, microcephaly, and developmental outcomes. J. Pediatr. 136:2000;57-61.
29. Waisbren S.E., Hanley W., Levy H.L., Shifrin H., Allred E.M.A., Azen C., Chang P.N., Cipcic-Scmidt S.D.P., dela Cruz F., Hall R., Matalon R., Nanson J., Rouse B., Trefz F., Koch R. Outcome at age 4 years in offspring of women with maternal phenylketonuria: the maternal PKU collaborative study. J. Am. Med. Assoc. 283:2000;756-762.
30. Fisch R.O., Matalon R., Weisberg S., Michals K. Phenylketonuria: current dietary treatment practices in the United States and Canada. J. Am. Coll. Nutr. 16(2):1997;147-151.
31. Chang P.N., Cook R.D., Fisch R.O. Prognostic factors of intellectual outcome of phenylketonurics: on and off diet. J. Psychiatr. Treat. Eval. 5:1983;157-163.
32. Bessman S.P., Williamson M.L., Koch R. Diet, genetics, and mental retardation interaction between phenylketonuric heterozygous mother and fetus to produce nonspecific diminution of IQ: evidence in support of justification hypothesis. Proc. Natl. Acad. Sci. USA. 75:1978;1562-1566.